BR112012002072A2 - polipeptídeos de fator ix modificados e usos dos mesmos - Google Patents
polipeptídeos de fator ix modificados e usos dos mesmosInfo
- Publication number
- BR112012002072A2 BR112012002072A2 BR112012002072A BR112012002072A BR112012002072A2 BR 112012002072 A2 BR112012002072 A2 BR 112012002072A2 BR 112012002072 A BR112012002072 A BR 112012002072A BR 112012002072 A BR112012002072 A BR 112012002072A BR 112012002072 A2 BR112012002072 A2 BR 112012002072A2
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptides
- modified factor
- factor
- modified
- Prior art date
Links
- 229960004222 factor ix Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23055109P | 2009-07-31 | 2009-07-31 | |
| PCT/US2010/044177 WO2011014890A1 (en) | 2009-07-31 | 2010-08-02 | Modified factor ix polypeptides and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012002072A2 true BR112012002072A2 (pt) | 2016-11-08 |
Family
ID=43529743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012002072A BR112012002072A2 (pt) | 2009-07-31 | 2010-08-02 | polipeptídeos de fator ix modificados e usos dos mesmos |
Country Status (21)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101557830B (zh) | 2006-12-15 | 2016-06-08 | 巴克斯特国际公司 | 具有延长的体内半衰期的因子VIIa-聚唾液酸结合物 |
| EP3581650B1 (en) | 2008-09-15 | 2022-12-28 | uniQure biopharma B.V. | Factor ix polypeptide mutant, its uses and a method for its production |
| EP3081233B1 (en) | 2009-07-27 | 2020-12-23 | Baxalta GmbH | Glycopolysialylation of proteins other than blood coagulation proteins |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| ES2856055T3 (es) | 2009-07-27 | 2021-09-27 | Baxalta GmbH | Glicopolisialilación de proteínas diferentes de las proteínas de coagulación de la sangre |
| CN102497884A (zh) | 2009-07-27 | 2012-06-13 | 巴克斯特国际公司 | 凝血蛋白缀合物 |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| KR102229967B1 (ko) * | 2010-07-30 | 2021-03-19 | 박스알타 인코퍼레이티드 | 옥심 결합용 친핵성 촉매 |
| WO2012087838A1 (en) | 2010-12-22 | 2012-06-28 | Baxter International Inc. | Materials and methods for conjugating a water soluble fatty acid derivative to a protein |
| WO2013095279A1 (en) * | 2011-12-19 | 2013-06-27 | Dilafor Ab | Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use |
| AU2013348029A1 (en) * | 2012-11-20 | 2015-07-02 | The University Of North Carolina At Chapel Hill | Methods and compositions for modified factor IX proteins |
| CN105121461A (zh) | 2013-03-13 | 2015-12-02 | 伊莱利利公司 | 修饰的犬瘦素多肽 |
| TW201519900A (zh) * | 2013-04-28 | 2015-06-01 | Bayer Healthcare Llc | 用於誘導對凝血因子蛋白之免疫耐受性的組成物及方法 |
| GB201420139D0 (en) | 2014-11-12 | 2014-12-24 | Ucl Business Plc | Factor IX gene therapy |
| UA126016C2 (uk) | 2015-08-03 | 2022-08-03 | Біовератів Терапеутікс Інк. | Злитий білок фактора іх |
| WO2018022844A2 (en) * | 2016-07-27 | 2018-02-01 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating factor ix function |
| US10842885B2 (en) | 2018-08-20 | 2020-11-24 | Ucl Business Ltd | Factor IX encoding nucleotides |
| GB201813528D0 (en) | 2018-08-20 | 2018-10-03 | Ucl Business Plc | Factor IX encoding nucleotides |
| MX2021004277A (es) | 2018-10-18 | 2021-09-08 | Intellia Therapeutics Inc | Composiciones y metodos para expresar el factor ix. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1520259A (zh) * | 2001-04-25 | 2004-08-11 | ���ݴ�ѧУ��ίԱ�� | 利用球状载体将第八因子/第九因子进行肝脏基因转移治疗血友病的方法 |
| WO2005055950A2 (en) * | 2003-12-03 | 2005-06-23 | Neose Technologies, Inc. | Glycopegylated factor ix |
| US20060040856A1 (en) * | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
| WO2007149406A2 (en) * | 2006-06-19 | 2007-12-27 | Nautilus Technology Llc | Modified coagulation factor ix polypeptides and use thereof for treatment |
| US7700734B2 (en) * | 2007-01-09 | 2010-04-20 | Shu-Wha Lin | Recombinant human factor IX and use thereof |
-
2010
- 2010-08-02 WO PCT/US2010/044177 patent/WO2011014890A1/en active Application Filing
- 2010-08-02 PE PE2012000114A patent/PE20121643A1/es not_active Application Discontinuation
- 2010-08-02 CN CN2010800431356A patent/CN102573890A/zh active Pending
- 2010-08-02 JP JP2012523129A patent/JP2013500726A/ja active Pending
- 2010-08-02 CA CA2769258A patent/CA2769258A1/en not_active Abandoned
- 2010-08-02 EP EP10805185.5A patent/EP2461821A4/en not_active Withdrawn
- 2010-08-02 AU AU2010278721A patent/AU2010278721A1/en not_active Abandoned
- 2010-08-02 SG SG2012005757A patent/SG178119A1/en unknown
- 2010-08-02 KR KR1020127005191A patent/KR20120060209A/ko not_active Withdrawn
- 2010-08-02 IN IN908DEN2012 patent/IN2012DN00908A/en unknown
- 2010-08-02 BR BR112012002072A patent/BR112012002072A2/pt not_active IP Right Cessation
- 2010-08-02 EA EA201290069A patent/EA201290069A1/ru unknown
- 2010-08-02 US US13/388,288 patent/US20120164130A1/en not_active Abandoned
- 2010-08-02 MX MX2012001346A patent/MX2012001346A/es not_active Application Discontinuation
-
2012
- 2012-01-27 DO DO2012000030A patent/DOP2012000030A/es unknown
- 2012-01-30 GT GT201200023A patent/GT201200023A/es unknown
- 2012-01-30 EC EC2012011637A patent/ECSP12011637A/es unknown
- 2012-01-30 ZA ZA2012/00716A patent/ZA201200716B/en unknown
- 2012-01-30 CR CR20120052A patent/CR20120052A/es unknown
- 2012-01-30 CL CL2012000238A patent/CL2012000238A1/es unknown
- 2012-01-30 CU CU20120018A patent/CU20120018A7/es unknown
-
2013
- 2013-04-19 CU CU2013000058A patent/CU20130058A7/es unknown
- 2013-04-19 CU CU2013000057A patent/CU20130057A7/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT201200023A (es) | 2014-01-27 |
| CL2012000238A1 (es) | 2012-10-05 |
| SG178119A1 (en) | 2012-03-29 |
| KR20120060209A (ko) | 2012-06-11 |
| EP2461821A4 (en) | 2013-07-03 |
| CN102573890A (zh) | 2012-07-11 |
| CU20130058A7 (es) | 2013-06-28 |
| DOP2012000030A (es) | 2012-02-29 |
| AU2010278721A1 (en) | 2012-02-16 |
| PE20121643A1 (es) | 2012-11-25 |
| EP2461821A1 (en) | 2012-06-13 |
| CU20120018A7 (es) | 2012-06-21 |
| ZA201200716B (en) | 2013-07-31 |
| JP2013500726A (ja) | 2013-01-10 |
| ECSP12011637A (es) | 2012-02-29 |
| CR20120052A (es) | 2012-06-04 |
| MX2012001346A (es) | 2012-02-17 |
| EA201290069A1 (ru) | 2012-07-30 |
| CA2769258A1 (en) | 2011-02-03 |
| IN2012DN00908A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-04-03 |
| US20120164130A1 (en) | 2012-06-28 |
| CU20130057A7 (es) | 2013-06-28 |
| WO2011014890A1 (en) | 2011-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0910702A2 (pt) | polipeptídeos de fator ix modificados e usos dos mesmos | |
| BR112012002072A2 (pt) | polipeptídeos de fator ix modificados e usos dos mesmos | |
| BR112012006501A2 (pt) | polipeptídios e usos dos mesmos | |
| HRP20190137T1 (hr) | Stabilne formulacije polipeptida i njihova uporaba | |
| BRPI1009455A2 (pt) | anticorpos anti-c40 e usos dos mesmos | |
| BRPI0911060A2 (pt) | polipeptídeos de fator vii que são modificados e usos dos mesmos | |
| DK3663399T3 (da) | Modificerede factor IX-polypeptider og anvendelser deraf | |
| SMT201600335B (it) | Proteine leganti eterodimeri e loro usi | |
| BR112012003709A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| BRPI0912198A2 (pt) | anticorpos anti-fn14 e usos dos mesmos | |
| BRPI1011404A2 (pt) | mutantes e usos dos mesmos | |
| BRPI0922790A2 (pt) | peptídeos de ligação sparc e usos dos mesmos | |
| BRPI0916515A2 (pt) | polipeptídeo de g-csf bovinos modificados e usos dos mesmos | |
| BR112015001628A2 (pt) | polipeptídeos de fator x modificados e uso dos mesmos | |
| BRPI0920927A2 (pt) | derivados de azaquinolinona e usos dos mesmos | |
| BR112012001260A2 (pt) | conjugados de epsilon-polilisina e o emprego dos mesmos | |
| BRPI1013029A2 (pt) | polipeptídeos bifuncionais | |
| BRPI1014997A2 (pt) | compostos heteroarila e usos dos mesmos | |
| BRPI1015918A2 (pt) | conjugados de peptídeo multiméricos e usos dos mesmos | |
| BR112012004731A2 (pt) | peptídeos derivados de wnt10 e uso dos mesmos | |
| BRPI0810172A2 (pt) | Polipeptídeos de fator vii modificado e seus usos | |
| HRP20160737T1 (hr) | Anti-her3-protutijela i njihove uporabe | |
| BR112014000055A2 (pt) | polipeptídeos de fusão de relaxina e usos dos mesmos | |
| BRPI0819909A2 (pt) | anticorpos antimesotelina e usos dos mesmos | |
| BRPI1010024A2 (pt) | derivados de aminopirrolidinona e uso dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |